Dendreon Corp (DNDN)

0.06
0.00 6.02
NASDAQ : Health Care
Prev Close 0.06
Open 0.06
Day Low/High 0.06 / 0.06
52 Wk Low/High 0.04 / 3.46
Volume 1.37M
Avg Volume 5.11M
Exchange NASDAQ
Shares Outstanding 158.72M
Market Cap 20.16M
EPS -1.95
P/E Ratio N/A
Div & Yield N.A. (N.A)
December 6th Options Now Available For Dendreon (DNDN)

December 6th Options Now Available For Dendreon (DNDN)

Investors in Dendreon Corp saw new options become available today, for the December 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new December 6th contracts and identified one put and one call contract of particular interest.

The Deal: After String of Miscues, Dendreon Likely on Block

The Deal: After String of Miscues, Dendreon Likely on Block

The one-time investor darling learned tough lessons about selling immunotherapy.

Stock To Watch: Dendreon (DNDN) In Perilous Reversal

Stock To Watch: Dendreon (DNDN) In Perilous Reversal

Trade-Ideas LLC identified Dendreon (DNDN) as a "perilous reversal" (up big yesterday but down big today) candidate

Stocks Cautious on Eve of Fed Meeting as Apple Reports

Stocks Cautious on Eve of Fed Meeting as Apple Reports

Markets close little changed as investors await the Federal Reserve's policy-making meeting.

Markets Mixed on Earnings

Markets Mixed on Earnings

Mixed earnings saw the Dow and Nasdaq close lower - though speculation on continued monetary stimulus helped the S&P post a gain.

November 29th Options Now Available For Dendreon (DNDN)

November 29th Options Now Available For Dendreon (DNDN)

Investors in Dendreon Corp saw new options become available today, for the November 29th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new November 29th contracts and identified one put and one call contract of particular interest.

First Week Of December 21st Options Trading For Dendreon (DNDN)

First Week Of December 21st Options Trading For Dendreon (DNDN)

Investors in Dendreon Corp saw new options begin trading this week, for the December 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new December 21st contracts and identified one put and one call contract of particular interest.

November 22nd Options Now Available For Dendreon (DNDN)

November 22nd Options Now Available For Dendreon (DNDN)

Investors in Dendreon Corp saw new options begin trading today, for the November 22nd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new November 22nd contracts and identified one put and one call contract of particular interest.

Looking for Low-Cost Outliers

Cheap stocks for investors who like to punt.

DNDN November 8th Options Begin Trading

DNDN November 8th Options Begin Trading

Investors in Dendreon Corp saw new options begin trading today, for the November 8th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new November 8th contracts and identified one put and one call contract of particular interest.

Dendreon To Host Conference Call On November 12 To Announce Third Quarter Financial Results

Dendreon To Host Conference Call On November 12 To Announce Third Quarter Financial Results

October 7, 2013 – Dendreon Corporation (Nasdaq: DNDN) today announced that management will host a conference call on Tuesday, November 12, 2013, at 9:00 a.

Dendreon Corporation Announces Presentation Of PROVENGE® (sipuleucel-T) Data At The 2013 European Cancer Congress

Dendreon Corporation Announces Presentation Of PROVENGE® (sipuleucel-T) Data At The 2013 European Cancer Congress

September 27, 2013 – Dendreon Corporation (NASDAQ: DNDN) announced today the presentation of data from clinical studies featuring PROVENGE ® (sipuleucel-T), an autologous cellular immunotherapy for...

Tracking the Shorts

When short sellers trip up, it can lead to spectacular gains.

First Week Of May 2014 Options Trading For Dendreon (DNDN)

First Week Of May 2014 Options Trading For Dendreon (DNDN)

Investors in Dendreon Corp saw new options become available this week, for the May 2014 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 233 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Your Guide to Deciphering Medivation's Most Important Prostate Cancer Drug Trial

Your Guide to Deciphering Medivation's Most Important Prostate Cancer Drug Trial

Positive results from the Xtandi clinical trial could turn the prostate cancer drug into a blockbuster.

Dendreon Announces Marketing Authorization For PROVENGE® In The European Union

Dendreon Announces Marketing Authorization For PROVENGE® In The European Union

September 17, 2013 – Dendreon Corporation (Nasdaq: DNDN) today announced that the European Commission (EC) has granted marketing authorization for PROVENGE ® (autologous peripheral blood mononuclear cells ...

Interesting DNDN Call For September 13th

Interesting DNDN Call For September 13th

Investors in Dendreon Corp saw new options become available today, for the September 13th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new September 13th contracts and identified the following call contract of particular interest.

September 6th Options Now Available For Dendreon (DNDN)

September 6th Options Now Available For Dendreon (DNDN)

Investors in Dendreon Corp saw new options begin trading today, for the September 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new September 6th contracts and identified the following call contract of particular interest.

Stock Futures Survive Nasdaq Glitch; Pandora Sinks

Stock Futures Survive Nasdaq Glitch; Pandora Sinks

U.S. stock futures are little changed Friday as investors await more details from the Jackson Hole Fed symposium and new-home sales data.

August 30th Options Now Available For Dendreon (DNDN)

August 30th Options Now Available For Dendreon (DNDN)

Investors in Dendreon Corp saw new options begin trading today, for the August 30th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new August 30th contracts and identified one put and one call contract of particular interest.

First Week Of October 19th Options Trading For Dendreon (DNDN)

First Week Of October 19th Options Trading For Dendreon (DNDN)

Investors in Dendreon Corp saw new options begin trading this week, for the October 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new October 19th contracts and identified one put and one call contract of particular interest.

DNDN August 23rd Options Begin Trading

DNDN August 23rd Options Begin Trading

Investors in Dendreon Corp saw new options become available today, for the August 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new August 23rd contracts and identified the following put contract of particular interest.

The Next Moves For 2 Spiking Biotech Stocks

The Next Moves For 2 Spiking Biotech Stocks

⿿Chris Lau, Kapitall: Quarterly earnings caused a spike in two biotechnology firms, but in different directions last week: Dendreon (DNDN) and [...]

The Provenge Anchor Is Sinking Dendreon

The Provenge Anchor Is Sinking Dendreon

Another bad sales quarter, pulled guidance and a fleeing CFO add it up to bad news for Dendreon.

Dendreon Announces Second Quarter 2013 Results

Dendreon Announces Second Quarter 2013 Results

August 8, 2013--Dendreon Corporation (Nasdaq: DNDN) today reported results for the second quarter ended June 30, 2013.

DNDN Makes Bullish Cross Above Critical Moving Average

DNDN Makes Bullish Cross Above Critical Moving Average

In trading on Monday, shares of Dendreon Corp crossed above their 200 day moving average of $4.83, changing hands as high as $5.38 per share. Dendreon Corp shares are currently trading up about 11.7% on the day.

Quick Take: Biotech's Next Big Thing Is Earnings

Quick Take: Biotech's Next Big Thing Is Earnings

It's time to review the mid-cap biotech stocks reporting second quarter results next week, says Adam Feuerstein, senior columnist at TheStreet.

Biotech's Next Big Thing: Earnings

Biotech's Next Big Thing: Earnings

It's time to review the mid-cap biotech stocks reporting second quarter results next week, says Adam Feuerstein, Sr. Columnist at TheStreet.

A Tale of Two Biotechs Under $10

A Tale of Two Biotechs Under $10

Biotech is a sector filled with speculation, risk, and potentially high reward. The fate of two companies -- one of which is now trading at less than $10 -- illustrates this.

Interesting DNDN Put And Call For September 21st

Interesting DNDN Put And Call For September 21st

Investors in Dendreon Corp saw new options become available this week, for the September 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the DNDN options chain for the new September 21st contracts and identified one put and one call contract of particular interest.